Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2003 1
2004 1
2006 4
2007 2
2008 3
2010 1
2012 4
2013 3
2014 7
2015 8
2016 11
2017 7
2018 11
2019 13
2020 10
2021 9
2022 12
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Introduction.
Trujillo L, Hu T, Lourenço N, Zhang M. Trujillo L, et al. Among authors: lourenco n. Genet Program Evolvable Mach. 2022;23(3):305-307. doi: 10.1007/s10710-022-09437-9. Epub 2022 Aug 20. Genet Program Evolvable Mach. 2022. PMID: 36035775 Free PMC article. No abstract available.
Copy number variations in a Brazilian cohort with autism spectrum disorders highlight the contribution of cell adhesion genes.
Costa CIS, da Silva Montenegro EM, Zarrei M, de Sá Moreira E, Silva IMW, de Oliveira Scliar M, Wang JYT, Zachi EC, Branco EV, da Costa SS, Lourenço NCV, Vianna-Morgante AM, Rosenberg C, Krepischi ACV, Scherer SW, Passos-Bueno MR. Costa CIS, et al. Among authors: lourenco ncv. Clin Genet. 2022 Jan;101(1):134-141. doi: 10.1111/cge.14072. Epub 2021 Nov 15. Clin Genet. 2022. PMID: 34664255
Three generation families: Analysis of de novo variants in autism.
Costa CIS, da Silva Campos G, da Silva Montenegro EM, Wang JYT, Scliar M, Monfardini F, Zachi EC, Lourenço NCV, Chan AJS, Pereira SL, Engchuan W, Thiruvahindrapuram B, Zarrei M, Scherer SW, Passos-Bueno MR. Costa CIS, et al. Among authors: lourenco ncv. Eur J Hum Genet. 2023 Sep;31(9):1017-1022. doi: 10.1038/s41431-023-01398-6. Epub 2023 Jun 6. Eur J Hum Genet. 2023. PMID: 37280359
Management of immune-related adverse events resulting from immune checkpoint blockade.
Baroudjian B, Arangalage D, Cuzzubbo S, Hervier B, Lebbé C, Lorillon G, Tazi A, Zalcman G, Bouattour M, Lioté F, Gautier JF, Brosseau S, Lourenco N, Delyon J; PATIO group. Baroudjian B, et al. Among authors: lourenco n. Expert Rev Anticancer Ther. 2019 Mar;19(3):209-222. doi: 10.1080/14737140.2019.1562342. Epub 2019 Jan 9. Expert Rev Anticancer Ther. 2019. PMID: 30572735 Review.
Stability of aerobic granules during long-term bioreactor operation.
Franca RDG, Pinheiro HM, van Loosdrecht MCM, Lourenço ND. Franca RDG, et al. Among authors: lourenco nd. Biotechnol Adv. 2018 Jan-Feb;36(1):228-246. doi: 10.1016/j.biotechadv.2017.11.005. Epub 2017 Nov 20. Biotechnol Adv. 2018. PMID: 29157974 Review.
Severe gastrointestinal toxicity of MEK inhibitors.
Mourad N, Lourenço N, Delyon J, Eftekhari P, Bertheau P, Allayous C, Ballon A, Pagès C, Allez M, Lebbé C, Baroudjian B; PATIO group. Mourad N, et al. Among authors: lourenco n. Melanoma Res. 2019 Oct;29(5):556-559. doi: 10.1097/CMR.0000000000000618. Melanoma Res. 2019. PMID: 31095035
Synthesis of 2,4,6-tri-substituted-1,3,5-triazines.
Afonso CA, Lourenço NM, Rosatella Ade A. Afonso CA, et al. Among authors: lourenco nm. Molecules. 2006 Jan 31;11(1):81-102. doi: 10.3390/11010081. Molecules. 2006. PMID: 17962749 Free PMC article.
Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.
Buisson A, Sokol H, Hammoudi N, Nancey S, Treton X, Nachury M, Fumery M, Hébuterne X, Rodrigues M, Hugot JP, Boschetti G, Stefanescu C, Wils P, Seksik P, Le Bourhis L, Bezault M, Sauvanet P, Pereira B, Allez M, Barnich N; Remind study group. Buisson A, et al. Gut. 2023 Jan;72(1):39-48. doi: 10.1136/gutjnl-2021-325971. Epub 2022 Mar 31. Gut. 2023. PMID: 35361684 Clinical Trial.
102 results